Skip to content
healthcare.dev
Get a free key

Alert Alertness Aid

NDC 50844-226, Caffeine, tablet, from L.N.K. International, Inc..

Product NDC
50844-226
Status
Listed
Labeler
L.N.K. International, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M011
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50844-226 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAFFEINE200 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
50844-226-1250844022612100 TABLET in 1 BOTTLE, PLASTIC (50844-226-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 50844-226 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50844-226 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50844-226. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.